Furthermore, the NRIP1 in the form of circulating RNA (circRNA) could become a potential biomarker of NAFLD/NASH-HCC, which needs further investigation (Table 1). Here, NRIP1 is linked to metabolic dysfunction-associated steatohepatitis.